71610 0474 60
Sotalol Hydrochloride Tablet
Product Images NDC 71610-474
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Age About 2 Years Or Younger (Age Factor)
Figure 2 (Figure2)
This text provides information about the P-values related to Recurrence-Free Survival for the drug Oral Sotalol compared to Placebo. It includes different dosages of Oral Sotalol (80 mg, 120 mg, and 160 mg) and their respective P-values. It is mostly likely related to a clinical study evaluating the effectiveness of Oral Sotalol in preventing recurrence of a certain medical condition.*
Figure 3 (Figure3)
Molecular Structure (Molecularstructure)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
